Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00559663 · ClinicalTrials.gov registry record · NA

Flavonoid Effect on Activation and Stimulation of Thrombocytes, hsCRP and Lipid Profile

A NA study, sponsored by LifeBridge Health.

Completed
Registry status
NA
Development phase
35
Enrollment target

NCT00559663 is a NA study that has completed, run by LifeBridge Health. The registered enrollment target is 35 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00559663, a NA study, has completed, sponsored by LifeBridge Health.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target

Study Summary

The purpose of this study is to compare the effect of dark chocolate with green tea in healthy subjects on clot formation (platelet activity) cholesterol profile and markers of inflammation in two groups. The first group will be on a regimen of dark chocolate, and the second group will be on a regimen of green tea. Clinical outcomes will be determined after seven days of each treatment and both groups will undergo both treatments subsequently and serve as their own control. The hypothesis is that both green tea and dark chocolate will reduce platelet activity and reduce LDL, hsCRP and increase HDL.

Interventions

  • DIETARY_SUPPLEMENT Green tea
  • DIETARY_SUPPLEMENT 70% dark chocolate

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2006-09
Est. Completion 2007-04
Phase NA

Sponsor

LifeBridge Health

14 total trials

What the Registry Record Tells You About NCT00559663

The ClinicalTrials.gov registry entry for NCT00559663 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LifeBridge Health, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Green tea is the first listed.

NCT00559663 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00559663 about?

NCT00559663 is a clinical study titled "Flavonoid Effect on Activation and Stimulation of Thrombocytes, hsCRP and Lipid Profile". The purpose of this study is to compare the effect of dark chocolate with green tea in healthy subjects on clot formation (platelet activity) cholesterol profile and markers of inflammation in two groups. The first group will be on a regimen of dark chocolate, and the second group will be on a regi...

What is the current status of trial NCT00559663?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2006-09. Estimated completion is 2007-04.

What interventions are being tested in trial NCT00559663?

The interventions under investigation include: Green tea (DIETARY_SUPPLEMENT), 70% dark chocolate (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00559663?

This trial is sponsored by LifeBridge Health, which has 14 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.